Chenglu Yuan

483 total citations
16 papers, 118 citations indexed

About

Chenglu Yuan is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Chenglu Yuan has authored 16 papers receiving a total of 118 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Chenglu Yuan's work include Platelet Disorders and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Blood groups and transfusion (4 papers). Chenglu Yuan is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Blood groups and transfusion (4 papers). Chenglu Yuan collaborates with scholars based in China, Sweden and Ethiopia. Chenglu Yuan's co-authors include Ming Hou, Zhencheng Wang, Hai Zhou, Jun Peng, Yu Hou, Xin Wang, Ming Yang, Jinyu Wei, Changchun Zhou and Qiang Liu and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Chenglu Yuan

14 papers receiving 117 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenglu Yuan China 5 74 36 30 26 22 16 118
Alejandro Medina Spain 6 40 0.5× 45 1.3× 40 1.3× 32 1.2× 32 1.5× 15 105
María Abáigar Spain 7 90 1.2× 82 2.3× 19 0.6× 44 1.7× 25 1.1× 16 150
Shlomzion Aumann Israel 7 53 0.7× 97 2.7× 24 0.8× 33 1.3× 51 2.3× 25 160
Immacolata Attolico Italy 6 82 1.1× 27 0.8× 28 0.9× 47 1.8× 44 2.0× 17 146
Hong L. Tiv United States 5 50 0.7× 68 1.9× 13 0.4× 22 0.8× 40 1.8× 7 130
Jorge Monge United States 7 72 1.0× 68 1.9× 21 0.7× 12 0.5× 46 2.1× 15 119
Christina Ganster Germany 8 64 0.9× 59 1.6× 30 1.0× 47 1.8× 13 0.6× 17 147
Wayne Rothbaum United States 6 32 0.4× 28 0.8× 43 1.4× 64 2.5× 37 1.7× 13 109
Stefan Köhrer Austria 4 32 0.4× 69 1.9× 54 1.8× 41 1.6× 42 1.9× 11 153
Felix Seyfried Germany 6 44 0.6× 74 2.1× 23 0.8× 38 1.5× 37 1.7× 16 145

Countries citing papers authored by Chenglu Yuan

Since Specialization
Citations

This map shows the geographic impact of Chenglu Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenglu Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenglu Yuan more than expected).

Fields of papers citing papers by Chenglu Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenglu Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenglu Yuan. The network helps show where Chenglu Yuan may publish in the future.

Co-authorship network of co-authors of Chenglu Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Chenglu Yuan. A scholar is included among the top collaborators of Chenglu Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenglu Yuan. Chenglu Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Sun, Lu, Juan Wang, Chenglu Yuan, et al.. (2024). Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial. Blood. 144(17). 1791–1799. 2 indexed citations
3.
Liu, Lu, Linlin Shao, Chenglu Yuan, et al.. (2024). E3 ubiquitin ligase casitas B-lineage lymphoma-b modulates T-cell anergic resistance via phosphoinositide 3-kinase signaling in patients with immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 22(4). 1202–1214. 1 indexed citations
4.
Yuan, Chenglu, et al.. (2024). Identifying key genes and functionally enriched pathways in acute myeloid leukemia by weighted gene co-expression network analysis. Journal of Applied Genetics. 66(2). 347–362. 1 indexed citations
6.
Wang, Feng‐Rong, Shihua Zhao, Yajun Li, et al.. (2023). Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study. Annals of Hematology. 102(11). 3185–3193.
7.
Yuan, Chenglu, et al.. (2023). DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features. Clinical and Experimental Medicine. 23(6). 2639–2649. 7 indexed citations
8.
Wang, Nana, et al.. (2023). SLED1 Promoting Cell Proliferation and Inhibiting Apoptosis in Acute Myeloid Leukemia: a Study. Applied Biochemistry and Biotechnology. 195(11). 6633–6652. 2 indexed citations
9.
Ni, Xiaofei, Daqi Li, Chenglu Yuan, et al.. (2022). Single‐dose versus low‐dose rituximab in corticosteroid‐resistant or relapsed ITP: A multicenter, randomized, controlled study. American Journal of Hematology. 97(4). 440–447. 4 indexed citations
10.
Sun, Lu, Juan Wang, Linlin Shao, et al.. (2021). Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial. The Lancet Haematology. 8(4). e289–e298. 32 indexed citations
11.
Zhou, Hai, Ping Qin, Qiang Liu, et al.. (2019). A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia. American Journal of Hematology. 94(12). 1374–1381. 35 indexed citations
13.
Li, Xuemei, et al.. (2018). Synchronous Hodgkin lymphoma and gastric adenocarcinoma. Medicine. 97(3). e9484–e9484. 3 indexed citations
14.
Liang, Rui, et al.. (2016). Functional polymorphisms of the cyclooxygenase-2 gene and prognosis of hepatocellular carcinoma - a cohort study in Chinese people. Genetics and Molecular Research. 15(2). 2 indexed citations
15.
Wei, Jinyu, et al.. (2014). The Functional TP53 rs1042522 and MDM4 rs4245739 Genetic Variants Contribute to Non-Hodgkin Lymphoma Risk. PLoS ONE. 9(9). e107047–e107047. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026